demonstrated that METTL3/METTL14 complex-mediated lncRNA IGFL2-AS1 m6A methylation results in VM formation in pazopanib resistant metastatic clear cell RCC (ccRCC) (158). This evidence concerns the gene IGFL2 and nonpapillary renal cell carcinoma.